US Patent Issued to ENLIVEX THERAPEUTICS R&D on April 15 for "Early apoptotic cells for use treating sepsis" (Israeli Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,714, issued on April 15, was assigned to ENLIVEX THERAPEUTICS R&D LTD (Nes-Ziona, Israel).

"Early apoptotic cells for use treating sepsis" was invented by Shai Novik (Ramat Hasharon, Israel) and Dror Mevorach (Jerusalem).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions disclosed herein, and methods of use thereof included those for treating or preventing sepsis in a subject in need, including methods of extending of the survival of a subject suffering from sepsis, and reduction of organ dysfunction or failure due to sepsis. Methods of treating or preventing sepsis in a subject in need includes administering compositions comprising early apo...